Literature DB >> 24324099

Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors.

Kiyoshi Maeda1, Masatsune Shibutani, Hiroshi Otani, Hisashi Nagahara, Kenji Sugano, Tetsuro Ikeya, Ryosuke Amano, Kenjiro Kimura, Katsunobu Sakurai, Naoshi Kubo, Kazuya Muguruma, Hiroaki Tanaka, Toru Inoue, Kosei Hirakawa.   

Abstract

BACKGROUND: The need for palliative resection of asymptomatic primary tumor in patients with unresectable metastatic colorectal cancer (CRC) is still controversial. In order to identify predictors of survival after palliative resection, we investigated the correlations between clinicopathological factors, preoperative Glasgow prognostic score (GPS) and neutrophil-to-lymphocyte ratio (NLR), and survival. PATIENTS AND METHODS: A total of 94 patients were enrolled in the present study. The prognostic value of the clinicopathological factors, GPS and NLR were analyzed retrospectively.
RESULTS: A multivariate analysis revealed that both the GPS and NLR were independent predictors of survival along with the preoperative Eastern Cooperative Oncology Group performance status (PS) and extent of distant metastasis. We classified the patients using a combination of these factors, and categorized them into three risk groups. The median survival time was five months in the high-risk group, compared to 21.5 months in the intermediate-risk group and 37 months in the low-risk group.
CONCLUSION: Sub-classification based on the GPS, NLR, PS and extent of distant metastasis can classify patients into three independent groups. There may be no survival benefits associated with palliative resection in the high-risk group.

Entities:  

Keywords:  Colorectal cancer; Glasgow prognostic score; asymptomatic primary tumor; neutrophil to lymphocyte ratio; palliative surgery; stage IV

Mesh:

Year:  2013        PMID: 24324099

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Hiroshi Ohtani; Katsunobu Sakurai; Sadaaki Yamazoe; Kenjiro Kimura; Takahiro Toyokawa; Ryosuke Amano; Hiroaki Tanaka; Kazuya Muguruma; Kosei Hirakawa
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

2.  Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Yasuhito Iseki; Tetsuro Ikeya; Kosei Hirakawa
Journal:  Oncol Lett       Date:  2016-12-12       Impact factor: 2.967

3.  Management of asymptomatic primary tumours in stage IV colorectal cancer: Review of outcomes.

Authors:  Kate Jessica Wilkinson; Wei Chua; Weng Ng; Aflah Roohullah
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

4.  Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.

Authors:  Tadanobu Shimura; Yuji Toiyama; Susumu Saigusa; Hiroki Imaoka; Masato Okigami; Hiroyuki Fujikawa; Junichiro Hiro; Minako Kobayashi; Masaki Ohi; Toshimitsu Araki; Yasuhiro Inoue; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  Int J Clin Oncol       Date:  2017-03-15       Impact factor: 3.402

5.  Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score-matching study.

Authors:  Zhongyi Zhou; Heming Ge; Yuqiang Li; Dan Wang; Cenap Güngör
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

6.  Prognostic Significance of the Immunological Indices in Patients Who Underwent Complete Resection of Pulmonary Metastases of Colorectal Cancer.

Authors:  Yuki Okazaki; Masatsune Shibutani; E N Wang; Hisashi Nagahara; Tatsunari Fukuoka; Yasuhito Iseki; Shinichiro Kashiwagi; Hiroaki Tanaka; Kiyoshi Maeda; Kosei Hirakawa; Masaichi Ohira
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 7.  Inflammation-based factors and prognosis in patients with colorectal cancer.

Authors:  Kiyoshi Maeda; Masatusne Shibutani; Hiroshi Otani; Hisashi Nagahara; Tetsuro Ikeya; Yasuhito Iseki; Hiroaki Tanaka; Kazuya Muguruma; Kosei Hirakawa
Journal:  World J Gastrointest Oncol       Date:  2015-08-15

8.  The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Hiroshi Ohtani; Yasuhito Iseki; Tetsuro Ikeya; Kenji Sugano; Kosei Hirakawa
Journal:  World J Surg Oncol       Date:  2015-06-04       Impact factor: 2.754

9.  The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Hiroshi Ohtani; Yasuhito Iseki; Tetsuro Ikeya; Kenji Sugano; Kosei Hirakawa
Journal:  BMC Cancer       Date:  2015-05-02       Impact factor: 4.430

10.  The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.

Authors:  Cui Chen; Peng Sun; Qiang-sheng Dai; Hui-wen Weng; He-ping Li; Sheng Ye
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.